NEOPLASMS, LUNG

Clinical trials for NEOPLASMS, LUNG explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS, LUNG trials appear

Sign up with your email to follow new studies for NEOPLASMS, LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New drug targets tough cancers with KRAS mutation

Disease control Ongoing

This study tests a new drug called JDQ443, alone or with other treatments, for people with advanced solid tumors that have a specific gene change called KRAS G12C. The goal is to find the best dose and see if it can shrink tumors or slow their growth. About 344 adults with lung, …

Matched conditions: NEOPLASMS, LUNG

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Jun 15, 2026 19:01 UTC

NEOPLASMS, LUNG

Get alerted when new NEOPLASMS, LUNG trials appear

New drug targets tough cancers with KRAS mutation